Arie Perry

Arie Perry, MD


Specialties: Brain and spinal cord tumors

Dr. Perry is a neuropathologist who specializes in the diagnosis of brain and spinal cord tumors. In addition to over 20 years’ experience as a pathologist, Dr. Perry also leads several translational research projects focusing on the development new diagnostic and prognostic markers for gliomas, meningiomas, and primitive pediatric malignancies. 

Dr. Perry’s specific research interests include the improvement of tumor classification and grading schemes, as well as the identification of molecular and genetic markers associated with tumorigenesis, malignant progression, and/or biologic behavior. His hope is that identifying new markers will improve patient management and lead to the development of novel therapeutic approaches. 


Education and Training

1986: BS, The University of Texas at Austin
1990: MD, UT Southwestern Medical Center
1994: Residency, Anatomic and Clinical Pathology, UT Southwestern Medical Center
1998: Fellowship; Surgical Pathology, Neuropathology, and Research; Mayo Clinic

Academic Positions

1997-1998: Instructor, Pathology, Mayo Clinic School of Medicine
1998-2003: Assistant Professor, Pathology, Washington University School of Medicine
2003-2008: Associate Professor, Pathology, Washington University School of Medicine
2008-2010: Professor, Pathology, Washington University School of Medicine
2009-2010: Professor, Neurosurgery, Washington University School of Medicine
2010-Present: Professor, Pathology, UCSF
2010-Present: Professor, Neurosurgery, UCSF
2010-Present, Director of Neuropathology, UCSF

Selected Awards

2018: Elected as a Board of Directors Member for the United States and Canadian Academy of Pathology
2018: Society for Neuro-Oncology in Latin America International Imaging and Pathology Recognition Award
2017: Member of International Collaboration on Cancer Reporting for the development of a reporting protocol for tumours of the central nervous system
2016: Member of cIMPACT‑NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy
2016: Appointed to the Editorial Advisory Board for the American Registry of Pathology Publications
2015: Appointed President of American Association of Neuropathologists for 2016-2017
2015: Appointed President Elect of American Association of Neuropathologists for 2015-2016
2014: Appointed as Senior Reviewer for World Health Organization 4th edition brain tumor classification scheme update
2014: Appointed Vice President of International Society of Neuropathology for 2015-2018
2012-2015: Served as North American Chief Editor for 9th Edition of Greenfield’s Neuropathology
2013: Nominated for MS1 Essential Core Teaching Award, UCSF
2009-Present: Best Doctors in America, U.S. News and World Reports